Hideo Yasunaga

Papers on Lattice

Total citations

Topics

h-index

Publication activitypapers/week, last 8 weeks

Frequent co-authors

Chanon Nusawat (1)So Sato (1)Jumpei Taniguchi (1)Y. Kimura (1)

Papers (1)

Mar 4, 2026

Chanon Nusawat +41w ago

Cost-effectiveness analysis of immune checkpoint inhibitors versus platinum-based doublet chemotherapy in the first-line treatment of advanced non-small-cell lung cancer with High PD-L1 expression in Japan.

Pembrolizumab is a cost-effective first-line treatment for advanced NSCLC with PD-L1 TPS with PD-L1 TPS in Japan, and atezolizumab is the least cost-effective.

Chanon Nusawat, So Sato, Jumpei Taniguchi +2

Search

Hideo Yasunaga

Publication activitypapers/week, last 8 weeks

Frequent co-authors

Papers (1)